Stay updated with breaking news from Cosmetics Rules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Bombay High Court on Wednesday admonished the State government, the appellate authority against drugs licence suspension orders, stating that a decision must not be kept pending for so long that...
The revised rules are expected to benefit companies focused on the domestic market. However, small companies may come under pressure because they may need a substantial capex to conform
A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The Schedule M of the Drugs and Cosmetics Rules specifies the good manufacturing practices (GMPs), which aim to ensure quality of drugs made in the country.
As online sales of substandard medicines surge, authorities face a daunting task in regulating and safeguarding public health. This was discussed during the pan-India chemist workshop held in Ahmedabad on Jan 7, which was attended by around 2,400 chemists from Ahmedabad and more than 34,000 chemists from around Gujarat.
One of the subsidiary company has received orders from Assistant Director & Drug Sales Licensing Authority, Drug Control administration from various locations.